Abstract
The effect of large doses of glucocorticoids on thyrotropin (TSH) secretion in normal and hypothyroid humans has been studied. Plasma TSH concentrations were measured before, during, and after treatment with dexamethasone given orally for 24-48 hr. In 17 patients with primary hypothyroidism, plasma TSH levels fell significantly during treatment to a mean of 54% of control (range 23-96%). Within 48 hr after the withdrawal of dexamethasone, TSH concentrations transiently increased above pretreatment values. The mean increase was to 156% of control (range 106-294). Similar changes, but of smaller magnitude, were observed in 15 normal subjects. Administration of single oral doses of dexamethasone and oral or intravenous doses of cortisol were followed by reduction of plasma TSH levels to 18-47% of control within 8-12 hr in eight hypothyroid patients. This fall also was followed by significant TSH rises above control values before they returned to the pretreatment levels. Mineralocorticoid administration was not followed by any changes in plasma TSH concentrations in three subjects.
TSH responses to steroid were also studied in rats. In hypothyroid rats given dexamethasone intravenously, plasma TSH fell to 63% of control in 30-90 min and then returned to normal or above in 3-4 hr. Dexamethasone also reduced plasma TSH concentrations in normal rats but no rebound was observed in these animals. Dexamethasone did not block the increase in plasma TSH produced by thyrotropin releasing factor (TRF) administration in vivo. Neither basal nor TRF-mediated TSH release from hemipituitaries in vitro was reduced by dexamethasone or corticosterone. These studies indicate that glucocorticoids reduce TSH secretion and suggest that this effect occurs at a suprahypophyseal level.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALBERT A. Thyroid gland. Annu Rev Physiol. 1952;14:481–498. doi: 10.1146/annurev.ph.14.030152.002405. [DOI] [PubMed] [Google Scholar]
- Abe K., Nicholson W. E., Liddle G. W., Island D. P., Orth D. N. Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest. 1967 Oct;46(10):1609–1616. doi: 10.1172/JCI105653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bowers C. Y., Schally A. V., Hawley W. D., Gual C., Parlow A. Effect of thyrotropin-releasing factor in man. J Clin Endocrinol Metab. 1968 Jul;28(7):978–982. doi: 10.1210/jcem-28-7-978. [DOI] [PubMed] [Google Scholar]
- CONDLIFFE P. G. Purification of human thyrotrophin. Endocrinology. 1963 Jun;72:893–896. doi: 10.1210/endo-72-6-893. [DOI] [PubMed] [Google Scholar]
- FRANTZ A. G., RABKIN M. T. HUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS. N Engl J Med. 1964 Dec 31;271:1375–1381. doi: 10.1056/NEJM196412312712701. [DOI] [PubMed] [Google Scholar]
- FREDRICKSON D. S., FORSHAM P. H., THORN G. W. The effect of massive cortisone therapy on measurements of thyroid function. J Clin Endocrinol Metab. 1952 May;12(5):541–553. doi: 10.1210/jcem-12-5-541. [DOI] [PubMed] [Google Scholar]
- FREINKEL N., INGBAR S. H. ACTH, cortisone and the metabolism of iodine. Metabolism. 1956 Nov;5(6 Pt 1):652–666. [PubMed] [Google Scholar]
- HARTOG M., GAAFAR M. A., FRASER R. EFFECT OF CORTICOSTEROIDS ON SERUM GROWTH HORMONE. Lancet. 1964 Aug 22;2(7356):376–378. doi: 10.1016/s0140-6736(64)90389-7. [DOI] [PubMed] [Google Scholar]
- INGBAR S. H., FREINKEL N. The influence of ACTH, cortisone, and hydrocortisone on the distribution and peripheral metabolism of thyroxine. J Clin Invest. 1955 Sep;34(9):1375–1379. doi: 10.1172/JCI103186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar R. S., Musa B. U., Appleton W. G., Dowling J. T. Effect of prednisone on thyroxine distribution. J Clin Endocrinol Metab. 1968 Sep;28(9):1335–1340. doi: 10.1210/jcem-28-9-1335. [DOI] [PubMed] [Google Scholar]
- LIDDLE G. W., ESTEP H. L., KENDALL J. W., Jr, WILLIAMS W. C., Jr, TOWNES A. W. Clinical application of a new test of pituitary reserve. J Clin Endocrinol Metab. 1959 Aug;19:875–894. doi: 10.1210/jcem-19-8-875. [DOI] [PubMed] [Google Scholar]
- MONEY W. L. The interrelation of the thyroid and the adrenals. Brookhaven Symp Biol. 1955 Feb;7:137-68; discussion, 218-9. [PubMed] [Google Scholar]
- Morris H. G., Jorgensen J. R., Jenkins S. A. Plasma growth hormone concentration in corticosteroid-treated children. J Clin Invest. 1968 Mar;47(3):427–435. doi: 10.1172/JCI105739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakagawa K., Horiuchi Y., Mashimo K. Responses of plasma growth hormone and corticosteroids to insulin and arginine with or without prior administration of dexamethasone. J Clin Endocrinol Metab. 1969 Jan;29(1):35–40. doi: 10.1210/jcem-29-1-35. [DOI] [PubMed] [Google Scholar]
- Odell W. D., Wilber J. F., Utiger R. D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res. 1967;23:47–85. doi: 10.1016/b978-1-4831-9826-2.50005-2. [DOI] [PubMed] [Google Scholar]
- Oppenheimer J. H., Werner S. C. Effect of prednisone on thyroxine-binding proteins. J Clin Endocrinol Metab. 1966 Jul;26(7):715–721. doi: 10.1210/jcem-26-7-715. [DOI] [PubMed] [Google Scholar]
- Wilber J. F., Utiger R. D. Immunoassay studies of thyrotropin in rat pituitary glands and serum. Endocrinology. 1967 Jul;81(1):145–151. doi: 10.1210/endo-81-1-145. [DOI] [PubMed] [Google Scholar]
- Wilber J. F., Utiger R. D. In vitro studies on mechanism of action of thyrotropin releasing factor. Proc Soc Exp Biol Med. 1968 Feb;127(2):488–490. doi: 10.3181/00379727-127-32722. [DOI] [PubMed] [Google Scholar]